In this extensive study, it was also reported that high baseline s-IGFBP-1 levels in a cohort without baseline diabetes (n = 1190) were associated with a reduced risk of developing type 2 diabetes over 10 years [14]. Here, IGFBP1 is linked to type 2 diabetes mellitus.